Updates are available Correction dated 2024-11-29
Click to view Correction: https://doi.org/10.1186/s12905-024-03466-5
-
Authors
Cordeiro, Alexandra A.
Moorhouse, Louisa
Dadirai, Tawanda
Maswera, Rufurwokuda
Chang, Angela Y.
Nyamukapa, Constance
Gregson, Simon
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/R015600/1, MR/R015600/1, MR/R015600/1)
Foundation for the National Institutes of Health (5R01MH114562-02, 5R01MH114562-02)
Bill and Melinda Gates Foundation (INV-009999)
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 24 October 2024
First Online: 6 November 2024
Change Date: 26 November 2024
Change Type: Update
Change Details: The original online version of this article was revised: in Figure 2, panel B was omitted and it has been updated.
Change Date: 29 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12905-024-03466-5
Declarations
:
: All study participants provided written informed consent before participation in the study. Informed consent was read to the participants by a trained member of the study team. The consent form used lay language and participants were provided with the opportunity to ask questions about the study prior to signing the consent form. Ethical clearance for this study was given by the Medical Research Council of Zimbabwe (MRCZ/A/2703) and the Imperial College Research Ethics Committee (20IC6436).The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
: Not applicable.
: SG declares shareholdings in pharmaceutical companies [GSK and Astra Zeneca]; all other authors have no conflicts of interest to declare.
